BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medela, Inc. Release: New Invia® Motion™ Offers Increased Patient Mobility and Freedom


5/2/2013 11:07:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MCHENRY, Ill., May 2, 2013 /PRNewswire/ -- Medela today announces the availability of Invia® Motion Negative Pressure Wound Therapy (NPWT) System for treating chronic and acute wounds. A personal device for every patient, Invia Motion offers a full choice of therapy options, and promotes improved patient mobility and freedom.

Invia Motion's small and lightweight design helps facilitate wound healing as it allows patients to be fully mobile and continue with normal daily activities. "The portability of the Invia Motion not only protects patient dignity and well-being, but also improves patient compliance which greatly impacts improvement in overall patient outcomes," states Rey Paglinawan, Medela NPWT medical research specialist who assisted in developing the product.

Designed with optimum hygiene in mind, every patient treated with an Invia Motion receives a new device. Each device and accessories provide up to 60 days of therapy which typically covers a patient's entire length of treatment. In addition, the system is flexible in offering a choice of constant or intermittent therapy modes, multiple pressure settings, and multiple drain options that can be used with either antimicrobial gauze or polyurethane foam dressings.

In recent post-market studies performed in the US and EU, patients appreciated the discrete operation of Invia Motion, as well as its quiet operation and simple handling; requiring only a few steps to operate. Clinicians who tested the product reported that the system offers more benefits when compared to similar products. Providing a simple and 'ready-to-go' system with an easy canister replacement technique and a user-friendly interface exceeded clinician and patient expectations during the testing.

About Medela

With over 50 years of leadership in medical vacuum technology, Medela has proven success in developing innovative and award winning products that deliver Swiss engineering quality and reliability. True NPWT by Medela provides clinicians with options in caring for patients that enhance overall therapy performance, help improve patient outcomes, and help control cost.

For more information about Invia Motion or other Medela products, e-mail inquiries to suction@medela.com, call (877) 694-6842, or visit www.medela.com.

Media Contact:
John Broughton
815.578.2325
john.broughton@medela.com

SOURCE Medela



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES